Our investigations identified three major invasiveness biomarkers not documented so far in integrative molecular studies characterizing MM [14], common to the three tumor sources, CAPG, FABP4, and LAMB2, and an additional set of candidate biomarkers shared by rat and patient tumors. This evidence concerns the gene CAPG and neoplasm.